权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Small Molecule Identification for the Nociceptin Receptor to Treat Cocaine Abuse

治疗可卡因滥用的伤害感受素受体的小分子鉴定

基本信息

批准号：
8462352
负责人：
Claes Robert Wahlestedt
金额：
$ 35.94万
依托单位：
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
依托单位国家：
美国
项目类别：
财政年份：
2012
资助国家：
美国
起止时间：
2012-06-01 至 2017-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8462352
关键词：
Affinity Agonist Alcohols Binding Biological Assay Cells Clinical Cocaine Cocaine Abuse Cocaine Dependence Coupling Data Dependence Development Disease Drug Receptors Evaluation Future GTP-Binding Proteins Goals Health Housing In Vitro Instruction Lead Life Ligands MAPK8 gene Mediating Molecular Nicotine Opioid Receptor Pathway interactions Peptides Pharmacology Pharmacotherapy Physiological Physiology Program Development Program Research Project Grants Publishing Receptor Activation Receptor Signaling Research Rewards Role Signal Pathway Signal Transduction Societies Staging Substance Addiction Substance of Abuse System Testing Therapeutic Therapeutic Agents Tissues Validation Work addiction base beta-arrestin cocaine receptor cocaine use counterscreen cytotoxicity delta opioid receptor design mu opioid receptors new therapeutic target nociceptin nociceptin receptor novel novel therapeutics pre-clinical receptor small molecule tool

项目摘要

The overall and specific goal of this application is the identification of novel high affinity and selective functional agonists of the nociceptin receptor that can be used to treat cocaine addiction. In previous efforts, we have identified, designed and synthesized novel, potent, and selective nociceptin receptor (a.k.a. ORL-1, NOP) agonists as tools for research on substance dependence with potential as clinically effective therapeutic agents. The disease target, cocaine abuse, represents an enormous health burden on society and for which currently available pharmacotherapies have insufficient efficacy. We propose nociceptin receptor agonism as a mechanism to achieve the therapeutic objective. Studies suggest that nociceptin activation opposes the dependence effects of substances of abuse such as nicotine, alcohol and cocaine. We propose nociceptin receptor activation as a mechanism to achieve the therapeutic objective of reduced cocaine addiction. While no clinical validation exists for the mechanism, the hypothesis supported by preclinical data, and would benefit from directed studies using optimized ligands, such as those we propose, to uncover the contributions of the nociceptin receptor to cocaine abuse as the first steps in developing novel therapeutics. In this application, we extend this molecule development program to center on the design, synthesis and evaluation of agents for that can be used in cocaine addiction research with potential to become therapeutics based on their actions at the nociceptin receptor. The pharmacology of novel compounds will be assessed in multiple cell-based assays and will include opioid receptor counterscreens to routinely determine potency and selectivity at a very early stage. The compound starting points for this project show no addictive potential, and a high level of selectivity over the mu opioid receptor, an improvement over currentiy available NOP agonists. This application is aimed at the development of the idea that nociceptin receptor agonists can be used to treat cocaine abuse. RELEVANCE (See instructions): Cocaine use represents an enormous worldwide health burden, in the US alone in 2009 more than 4.8 million people abused cocaine. Current cocaine use therapies are simply not effective and novel therapeutics are greatly needed. This project will test the hypothesis that the nociceptin receptor is involved in cocaine reward pathways in an attempt to validate the nociceptin receptor as a target for novel therapeutics to treat cocaine abuse.

该应用程序的总体和具体目标是鉴定新的高亲和力和